Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

SMC Update - April 2017

The Scottish Medicines Consortium (SMC) has issued its monthly advice on newly licensed medicines.

Emtricitabine / Tenofovir (Truvada®) has been accepted for use in combination with safer sex practices for pre-exposure prophylaxis to reduce the risk of sexually acquired HIV-1 infection in adults at high risk. It should denoted that NHS Boards in Scotland will make it available within the next three months when systems are in place.

Insulin aspart (Fiasp®) has been accepted for the treatment of diabetes mellitus in adults. It is noted that this is a new formulation with a faster onset of action than another formulation of insulin aspart and is available at an equivalent cost.

Ticagrelor (Brilique®) has been rejected for use when co-administered with acetylsalicylic acid for the prevention of atherothrombotic events in adult patients with a history of myocardial infarction and a high risk of developing an atherothrombotic event. The manufacturer did not present a sufficiently robust clinical and economic analysis to gain acceptance.

Action: Clinicians should be aware of the recommendations of the SMC. Routine use of rejected and restricted medicines should be avoided.

Share 'SMC Update - April 2017' on Email Share 'SMC Update - April 2017' on Delicious Share 'SMC Update - April 2017' on Digg Share 'SMC Update - April 2017' on Facebook Share 'SMC Update - April 2017' on Google+ Share 'SMC Update - April 2017' on reddit Share 'SMC Update - April 2017' on StumbleUpon Share 'SMC Update - April 2017' on Twitter

CKS Updates - March 2017

During March 2017 Clinical Knowledge Summaries were updated for the following topics:

The following topics were all reviewed:

The topics have undergone minor restructures. The most significant change is that all people presenting with suspected TIA within the last week should be referred urgently (to be seen within 24 hours) to a stroke physician without risk stratification.

Action: Clinicians who see patients with any of these conditions may find the new and updated information useful when reviewing current clinical practice.

Share 'CKS Updates - March 2017' on Email Share 'CKS Updates - March 2017' on Delicious Share 'CKS Updates - March 2017' on Digg Share 'CKS Updates - March 2017' on Facebook Share 'CKS Updates - March 2017' on Google+ Share 'CKS Updates - March 2017' on reddit Share 'CKS Updates - March 2017' on StumbleUpon Share 'CKS Updates - March 2017' on Twitter

Prescribing Advice for GPs is powered by WordPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.
Akismet has protected Prescribing Advice for GPs from 789,015 spam comments.

atomic-wealth
fond-illness
summer